top of page

CHO-K1/Rat MT2 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0148C

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


MT2 (Melatonin Receptor 1B, MTNR1B) is one of the two primary high-affinity G protein-coupled receptors for melatonin, co-mediating melatonin signaling with MT1. It is mainly distributed in the retina, suprachiasmatic nucleus of the brain, and peripheral tissues such as pancreatic islet β-cells. Its core functions include participating in dark-adaptation signal transmission in the retina and acting as a “circadian fine-tuner” in the central nervous system, regulating sleep onset and body temperature decline via Gi/o protein pathways. Peripherally, it directly inhibits insulin secretion from pancreatic β-cells, contributing to glucose homeostasis. Genetic polymorphisms of this receptor are significantly associated with the risk of type 2 diabetes, highlighting its role as a key molecule linking the circadian clock to metabolic regulation.

 

Screeningbio’s CHO-K1/Rat MT2 cell line overexpress Rat MTNR1B and is designed to detect inhibition in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Rat

HGNC Symbol

MTNR1B

Accession Number

SNB-G-0148C

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Rat MT2 Agonist Assay. CHO-K1/Rat MT2 cells were stimulated with 2.5 μM Forskolin and treated with reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Rat MT2 Agonist Assay. CHO-K1/Rat MT2 cells were stimulated with 2.5 μM Forskolin and treated with reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


MT2 (Melatonin Receptor 1B, MTNR1B) is one of the two primary high-affinity G protein-coupled receptors for melatonin, co-mediating melatonin signaling with MT1.


It is mainly distributed in the retina, suprachiasmatic nucleus of the brain, and peripheral tissues such as pancreatic islet β-cells. Its core functions include participating in dark-adaptation signal transmission in the retina and acting as a “circadian fine-tuner” in the central nervous system, regulating sleep onset and body temperature decline via Gi/o protein pathways. Peripherally, it directly inhibits insulin secretion from pancreatic β-cells, contributing to glucose homeostasis.


Genetic polymorphisms of this receptor are significantly associated with the risk of type 2 diabetes, highlighting its role as a key molecule linking the circadian clock to metabolic regulation.

Product Documentation



bottom of page